Valamparampil Joseph J, Gupte Girish L
Liver Unit, Birmingham Children's Hospital, Birmingham B4 6NH, United Kingdom.
World J Hepatol. 2021 Nov 27;13(11):1727-1742. doi: 10.4254/wjh.v13.i11.1727.
Cystic fibrosis (CF) is an autosomal recessive disorder caused by mutations in the CF transmembrane conductance regulator gene. CF liver disease develops in 5%-10% of patients with CF and is the third leading cause of death among patients with CF after pulmonary disease or lung transplant complications. We review the pathogenesis, clinical presentations, complications, diagnostic evaluation, effect of medical therapies especially CF transmembrane conductance regulator modulators and liver transplantation in CF associated liver disease.
囊性纤维化(CF)是一种常染色体隐性疾病,由CF跨膜传导调节因子基因突变引起。5%-10%的CF患者会发生CF肝脏疾病,它是CF患者继肺部疾病或肺移植并发症之后的第三大死因。我们综述了CF相关肝脏疾病的发病机制、临床表现、并发症、诊断评估、药物治疗尤其是CF跨膜传导调节因子调节剂的作用以及肝移植情况。